131 related articles for article (PubMed ID: 37866563)
1. STC2 is a potential biomarker of hepatocellular carcinoma with its expression being upregulated in Nrf1α-deficient cells, but downregulated in Nrf2-deficient cells.
Bu Q; Deng Y; Wang Q; Deng R; Hu S; Pei Z; Zhang Y
Int J Biol Macromol; 2023 Dec; 253(Pt 8):127575. PubMed ID: 37866563
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic Activation of Nrf2, Though as a Master Antioxidant Transcription Factor, Liberated by Specific Knockout of the Full-Length Nrf1α that Acts as a Dominant Tumor Repressor.
Qiu L; Wang M; Hu S; Ru X; Ren Y; Zhang Z; Yu S; Zhang Y
Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30562963
[TBL] [Abstract][Full Text] [Related]
3. Genetic loss of Nrf1 and Nrf2 leads to distinct metabolism reprogramming of HepG2 cells by opposing regulation of the PI3K-AKT-mTOR signalling pathway.
Deng R; Zhu Y; Liu K; Zhang Q; Hu S; Wang M; Zhang Y
Bioorg Chem; 2024 Apr; 145():107212. PubMed ID: 38377819
[TBL] [Abstract][Full Text] [Related]
4. Nrf1 Is Endowed with a Dominant Tumor-Repressing Effect onto the Wnt/
Chen J; Wang M; Xiang Y; Ru X; Ren Y; Liu X; Qiu L; Zhang Y
Oxid Med Cell Longev; 2020; 2020():5138539. PubMed ID: 32273945
[TBL] [Abstract][Full Text] [Related]
5. Loss of Nrf1 rather than Nrf2 leads to inflammatory accumulation of lipids and reactive oxygen species in human hepatoma cells, which is alleviated by 2-bromopalmitate.
Deng R; Zheng Z; Hu S; Wang M; Feng J; Mattjus P; Zhang Z; Zhang Y
Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119644. PubMed ID: 37996059
[TBL] [Abstract][Full Text] [Related]
6. TALENs-directed knockout of the full-length transcription factor Nrf1α that represses malignant behaviour of human hepatocellular carcinoma (HepG2) cells.
Ren Y; Qiu L; Lü F; Ru X; Li S; Xiang Y; Yu S; Zhang Y
Sci Rep; 2016 Apr; 6():23775. PubMed ID: 27065079
[TBL] [Abstract][Full Text] [Related]
7. STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro.
Wang H; Wu K; Sun Y; Li Y; Wu M; Qiao Q; Wei Y; Han ZG; Cai B
BMB Rep; 2012 Nov; 45(11):629-34. PubMed ID: 23187001
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma.
Wang Y; Wu J; Xu J; Lin S
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30962272
[TBL] [Abstract][Full Text] [Related]
9. Distinct mechanisms by which Nrf1 and Nrf2 as drug targets contribute to the anticancer efficacy of cisplatin on hepatoma cells.
Wufuer R; Liu K; Feng J; Wang M; Hu S; Chen F; Lin S; Zhang Y
Free Radic Biol Med; 2024 Mar; 213():488-511. PubMed ID: 38278308
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein promotes hepatocarcinogenesis via the activation of HMGA2/STC2 signaling to counteract oxidative stress-induced cell death.
Huang FY; Wong DK; Mak LY; Cheung TT; Seto WK; Yuen MF
Carcinogenesis; 2022 Aug; 43(7):671-681. PubMed ID: 35353897
[TBL] [Abstract][Full Text] [Related]
11. TCF11 Has a Potent Tumor-Repressing Effect Than Its Prototypic Nrf1α by Definition of Both Similar Yet Different Regulatory Profiles, With a Striking Disparity From Nrf2.
Wang M; Ren Y; Hu S; Liu K; Qiu L; Zhang Y
Front Oncol; 2021; 11():707032. PubMed ID: 34268128
[TBL] [Abstract][Full Text] [Related]
12. STC2 as a novel mediator for Mus81-dependent proliferation and survival in hepatocellular carcinoma.
Wu F; Li TY; Su SC; Yu JS; Zhang HL; Tan GQ; Liu JW; Wang BL
Cancer Lett; 2017 Mar; 388():177-186. PubMed ID: 27939696
[TBL] [Abstract][Full Text] [Related]
13. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
14. Glucose Starvation-Induced Rapid Death of Nrf1
Zhu YP; Zheng Z; Xiang Y; Zhang Y
Oxid Med Cell Longev; 2020; 2020():4959821. PubMed ID: 32774674
[TBL] [Abstract][Full Text] [Related]
15. STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial-Mesenchymal Transition.
Lin C; Sun L; Huang S; Weng X; Wu Z
Biomed Res Int; 2019; 2019():8042489. PubMed ID: 32258098
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma.
Zhang M; Zhang C; Zhang L; Yang Q; Zhou S; Wen Q; Wang J
BMC Cancer; 2015 Jul; 15():531. PubMed ID: 26194347
[TBL] [Abstract][Full Text] [Related]
17. Sp1 contributes to overexpression of stanniocalcin 2 through regulation of promoter activity in colon adenocarcinoma.
Li JB; Liu ZX; Zhang R; Ma SP; Lin T; Li YX; Yang SH; Zhang WC; Wang YP
World J Gastroenterol; 2019 Jun; 25(22):2776-2787. PubMed ID: 31236000
[TBL] [Abstract][Full Text] [Related]
18. NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma.
Leung HW; Lau EYT; Leung CON; Lei MML; Mok EHK; Ma VWS; Cho WCS; Ng IOL; Yun JP; Cai SH; Yu HJ; Ma S; Lee TKW
Cancer Lett; 2020 Apr; 476():48-56. PubMed ID: 32061952
[TBL] [Abstract][Full Text] [Related]
19. Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target.
Qie S; Sang N
J Exp Clin Cancer Res; 2022 May; 41(1):161. PubMed ID: 35501821
[TBL] [Abstract][Full Text] [Related]
20. NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines.
Haque E; Śmiech M; Łuczyńska K; Bouchard MF; Viger R; Kono H; Pierzchała M; Taniguchi H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
